Oura Ring Gen 4 sensor data — not clinical measurementsN=1 case study — not validated for clinical decisionsHEV diagnosed Mar 18; interpret findings cautiously in this Day 20 post-ruxolitinib window

Activity-Recovery Coupling

Module 4: Comparative Activity-Recovery Analysis
Generated 2026-04-05 19:38 · Henrik (post-HSCT) vs Mitchell (post-Stroke)
HENRIK COUPLING r
Absent
-0.007
Steps vs HRV (lag 1, n=79)
MITCHELL COUPLING r
Absent
-0.092
Steps vs HRV (lag 1, n=518)
DIFFERENCE (FISHER z)
Not significant
0.488
p-value for coupling difference
HENRIK RECOVERY
Abnormal
Decoupled
negligible absent
MITCHELL RECOVERY
Abnormal
Decoupled
negligible absent

Executive Summary

This report examines whether physical activity on day N predicts sleep quality and autonomic recovery on day N+1 for both patients. Henrik (post-HSCT, ~2700 steps/day, HRV ~9ms) shows absent coupling (r=-0.007). Mitchell (post-stroke, ~10000 steps/day, HRV ~43ms) shows absent coupling (r=-0.092).

Both patients show absent activity-recovery coupling.

Activity vs Next-Day Recovery

Cross-Correlation Functions

Positive lags = activity leads recovery (causal direction). Negative lags = recovery leads activity (reverse check). * indicates p < 0.10.

Dose-Response: Activity Bins vs Next-Day HRV

PatientN pairsBinsKruskal Hp-valueSig (p<0.10)
Henrik (post-HSCT)7940.21p=0.976No
Mitchell (post-Stroke)51849.03p=0.029Yes

Full Correlation Matrices (Lag 1)

Each cell shows Spearman r for activity[N] vs recovery[N+1]. * indicates p < 0.10. Colorscale: blue=positive, red=negative.

Steps vs Recovery Across Lags

Clinical Interpretation

Henrik (post-HSCT)

Coupling: absent (negligible) — r=-0.007, p=p=0.951, n=79
Recovery capacity: Decoupled
Activity and next-day recovery are effectively uncoupled. Other factors may dominate recovery dynamics.

Mitchell (post-Stroke)

Coupling: absent (negligible) — r=-0.092, p=p=0.036, n=518
Recovery capacity: Decoupled
Activity and next-day recovery are effectively uncoupled. Other factors may dominate recovery dynamics.

Cross-Patient Comparison

Both patients show absent activity-recovery coupling.

Fisher r-to-z test p-value: p=0.488

Caveats

  • Henrik has only ~79 usable lag-1 pairs. With small N, many true correlations will not reach statistical significance. Effect sizes (r values) are more informative than p-values.
  • Relaxed significance threshold (p < 0.10) used throughout to balance Type I and Type II error with limited data.
  • Observational design: correlations do not establish causation. Confounders (illness severity, medication, stress) are not controlled.
  • Henrik's extremely low activity level (~2700 steps, ~6 min active) provides limited variance to detect dose-response relationships.
  • Oura readiness 'resting_heart_rate' is a 0-100 score, NOT bpm. Heart rate values come from sleep_periods only.